ResMed announced it will release its second quarter fiscal 2026 financial and operational results on Thursday, January 29, 2026, immediately following the close of the New York Stock Exchange. Management will host a live webcast at 1:30 p.m. PST (4:30 p.m. EST) on the same day, with international access at 9:30 p.m. GMT (London) and 8:30 a.m. AEDT (Sydney) on January 30. Investors can access the presentation exclusively through ResMed’s investor relations portal (https://investor.resmed.com). A replay will be available on the website roughly two hours post-webcast, and a phone replay (Conference ID: 13757750) will run from January 29 through February 12 via U.S. and international access numbers.

ResMed continues to see robust demand for its AI-powered, cloud-connected sleep and respiratory devices across more than 140 markets. Management cites double-digit year-over-year unit growth in key regions and a 15% increase in recurring software subscription revenue during the first quarter, underscoring the strategic shift toward digital health solutions. The company entered the second quarter with cash and short-term investments exceeding $2.5 billion, providing ample liquidity for targeted R&D investments and potential bolt-on acquisitions. Investors should note, however, that global supply-chain constraints and increasing healthcare reimbursement scrutiny could pressure margins and growth in the back half of fiscal 2026.